WHO international standard for SARS-CoV-2 antibodies to determine markers of protection

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection

書誌詳細
主要な著者:	Zhu, F, Althaus, T, Tan, CW, Costantini, A, Chia, WN, Van Vinh Chau, N, Van Tan, L, Mattiuzzo, G, Rose, NJ, Voiglio, E, Wang, L-F
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2021

類似資料

Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard
著者:: Lidong Guan, 等
出版事項: (2023-02-01)

WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community
著者:: Ivana Knezevic, PhD, 等
出版事項: (2022-03-01)

Standardization of SARS-CoV-2 Nucleic Acid Amplification Techniques by Calibration and Quantification to the First WHO International Standard for SARS-CoV-2 RNA
著者:: Jolanda J. C. Voermans, 等
出版事項: (2023-01-01)

Maritime Public Health Cross Border Cooperation: Principality of Monaco and Italian Liguria Health Port Authority Best Practices
著者:: Antonello Campagna, 等
出版事項: (2022-12-01)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
著者:: Jeewandara, C, 等
出版事項: (2021)

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins
著者:: Adam Leach, 等
出版事項: (2021-05-01)

First clinical study of a new virus-inhibiting surgical glove
著者:: JL Caillot, 等
出版事項: (2008-01-01)

Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
著者:: Chau, NVV, 等
出版事項: (2021)

How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022
著者:: Thomas Althaus, 等
出版事項: (2024-06-01)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
著者:: Kuan-Ting Liu, 等
出版事項: (2022-07-01)

Antibody Response following Exposure to SARS-CoV-2: Is It a Reliable Marker of Immunity?
著者:: Mona Dhakal, 等
出版事項: (2022-04-01)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
著者:: Andrea Lombardi, 等
出版事項: (2022-12-01)

Expression of Embryonic Stem Cell Markers on the Microvessels of WHO Grade I Meningioma
著者:: Ganeshwaran Shivapathasundram, 等
出版事項: (2018-10-01)

Selection of a SARS-CoV-2 antibody quantification method and development of an antibody reference standard for ELISA to test immunoglobulin preparations
著者:: T. I. Smolyanova, 等
出版事項: (2022-12-01)

Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors
著者:: F. A. Quee, 等
出版事項: (2023-07-01)

Establishment of the First National Standard for Neutralizing Antibodies against SARS-CoV-2 XBB Variants
著者:: Xuanxuan Zhang, 等
出版事項: (2024-04-01)

SARS-CoV-2 spike S2-specific neutralizing antibodies
著者:: Chia-Jung Li, 等
出版事項: (2023-12-01)

WHO expert committee on biological standardization
出版事項: (2006-04-01)

Evaluation of specific IgG antibody in subjects who had been previously infected with SARS-CoV-2
著者:: Soodabeh Rostami, 等
出版事項: (2023-01-01)

Who benefits most?
著者:: L. Van Diermen
出版事項: (2021-04-01)

ANTIBODIES AGAINST THYROID AND THYROID STIMULATING HORMONE (TSH): WHO’S WHO?
著者:: Adina Ghemigian, 等
出版事項: (2018-06-01)

Neutralizing Antibody Spectrum in COVID-19 Patients who Became Ill During the Circulation of Different SARS-CoV-2 Variants
著者:: S. K. Pylaeva, 等
出版事項: (2024-11-01)

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
著者:: van Dorp, L, 等
出版事項: (2020)

Importation of Alpha and Delta variants during the SARS-CoV-2 epidemic in Switzerland: Phylogenetic analysis and intervention scenarios.
著者:: Martina L Reichmuth, 等
出版事項: (2023-08-01)

Prevalence of SARS-CoV-2 antibodies at the University hospital Heidelberg and correlation with SARS-CoV-2 incidence
著者:: C. Bundschuh, 等
出版事項: (2024-11-01)

Effect of the SARS-CoV-2 pandemic on treatment processes of patients with severe asthma who were managed with monoclonal antibody
著者:: Emel Atayık, 等
出版事項: (2022-10-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
著者:: Ren Yang, 等
出版事項: (2020-08-01)

Using Immunoglobulin G Spike Antibodies as a Surrogate Marker for SARS-CoV-2 Infection: Additional Considerations
著者:: Hinpetch Daungsupawong, PhD, 等
出版事項: (2024-01-01)

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
著者:: Matthew S. Durstenfeld, 等
出版事項: (2022-05-01)

Concorrência e Corrupção – Programas de Compliance no Debate Jurídico-Institucional Brasileiro
著者:: Marcela Mattiuzzo
出版事項: (2017-05-01)

ALGORITHMS AND BIG DATA: CONSIDERATIONS ON ALGORITHMIC GOVERNANCE AND ITS CONSEQUENCES FOR ANTITRUST ANALYSIS
著者:: Marcela Mattiuzzo

SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame
著者:: Wanda G. H. Han, 等
出版事項: (2022-05-01)

New WHO child growth standards catch on

New WHO child growth standards catch on
出版事項: (2011-04-01)

WHO to develop new child growth standards
出版事項: (2004-09-01)

The WHO healthcare standards in the context of demographic processes
著者:: Małgorzata Pabiś, 等
出版事項: (2018-12-01)

Circulating anti-retinal antibodies as immune markers in age-related macular degeneration.
著者:: Patel, N, 等
出版事項: (2005)

Characterization of antibody interactions with the G protein of vesicular stomatitis virus Indiana strain and other vesiculovirus G proteins
著者:: Munis, A, 等
出版事項: (2018)

Who is the sinner? The view of Karl Barth
著者:: F.J. van Zyl
出版事項: (2007-05-01)

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy
著者:: Wang T, 等
出版事項: (2022-10-01)